Development, differentiation and degenerative disease

Berry, C. L.
March 1983
Journal of the Royal Society of Medicine;Mar1983, Vol. 76 Issue 3, p176
Academic Journal
The article discusses the role of developmental changes and human variation on the development of diseases. Despite being the source of biological strength, variation in man may also result to enhanced susceptibiliy to degenerative disease. The author discusses the contribution of developmental changes to this enhanced susceptibility for the cardiovascular system and for some aspects of neoplasia.


Related Articles

  • The Impact of Familial Predisposition to Obesity and Cardiovascular Disease on Childhood Obesity. Nielsen, Louise Aas; Nielsen, Tenna Ruest Haarmark; Holm, Jens-Christian // Obesity Facts: The European Journal of Obesity;Oct2015, Vol. 8 Issue 5, p319 

    The prevalence of childhood obesity has reached alarming rates world-wide. The aetiology seems to be an interplay between genetic and environmental factors, and a surrogate measure of this complex interaction is suggested as familial predisposition. Familial predisposition to obesity and related...

  • Previniendo enfermedades crónico-degenerativas con vacunas sociales. Gershenson, Carlos; Wisdom, Thomas N. // Cirugia y Cirujanos;mar/abr2013, Vol. 81 Issue 2, p83 

    No abstract available.

  • Studying Genetic Variations in Cancer Prognosis (and Risk): A Primer for Clinicians. Savas, Sevtap; Liu, Geoffrey // Oncologist;Jul2009, Vol. 14 Issue 7, p657 

    Rare, high-penetrance genetic variations account for a small portion of genetic cancer syndromes. In contrast, most cancers develop from a combination of minor genetic influences and environmental factors. There are numerous publications on cancer susceptibility. In contrast, genetic studies in...

  • Survival Differences by Race/Ethnicity and Treatment for Localized Hepatocellular Carcinoma Within the United States. Wong, Robert J.; Corley, Douglas A. // Digestive Diseases & Sciences;Sep2009, Vol. 54 Issue 9, p2031 

    Racial differences among hepatocellular carcinoma survival have been reported, but the etiology behind these disparities remains unclear. Using multi-variable logistic regression analysis, our restrospective cohort study investigated the demographic disparities in survival among localized...

  • Genotype and haplotype analysis of TP53 gene and the risk of pancreatic cancer: an association study in the Czech Republic. Naccarati, A.; Pardini, B.; Polakova, V.; Smerhovsky, Z.; Vodickova, L.; Soucek, P.; Vrana, D.; Holcatova, I.; Ryska, M.; Vodicka, P. // Carcinogenesis;Apr2010, Vol. 31 Issue 4, p666 

    Pancreatic carcinoma is the fourth leading cause of cancer-related deaths in the Czech Republic, with only a minimum of patients surviving 5 years. The aetiology and molecular pathogenesis are still weakly understood. TP53 has a fundamental role in cell cycle and apoptosis and is frequently...

  • Colorectal cancer REGORAFENIB SHOWS BENEFIT IN PHASE III CORRECT TRIAL. Samson, Benoît // Oncology Exchange;May2012, Vol. 11 Issue 2, p1 

    The article presents a study which examines the efficacy of Regorafenib in treating colorectal cancer. The study was conducted to evaluate the efficacy and safety of Regorafenib in patients with metastatic colorectal cancer (mCRC) who had progression during the last 3 months after last standard...

  • Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960. Ahmad, A S; Ormiston-Smith, N; Sasieni, P D // British Journal of Cancer;3/3/2015, Vol. 112 Issue 5, p943 

    Background:Typically, lifetime risk is calculated by the period method using current risks at different ages. Here, we estimate the probability of being diagnosed with cancer for individuals born in a given year, by estimating future risks as the cohort ages.Methods:We estimated the lifetime...

  • Prostate cancer: 3. Individual risk factors. Gallagher, Richard P.; Fleshner, Neil // CMAJ: Canadian Medical Association Journal;10/06/98, Vol. 159 Issue 7, p807 

    Discusses individual risk factors for prostate cancer in Canada. National and ethnic differences; Family history and genetic predisposition; Diet; Body mass and physical activity; Vasectomy; Hormonal and sexual factors; Sexual history; Occupational exposure; Conclusions.

  • Functional Impact of Missense Variants in BRCA1 Predicted by Supervised Learning. Karchin, Rachel; Monteiro, Alvaro N. A.; Tavtigian, Sean V.; Carvalho, Marcelo A.; Sali, Andrej // PLoS Computational Biology;Feb2007, Vol. 3 Issue 2, p268 

    Many individuals tested for inherited cancer susceptibility at the BRCA1 gene locus are discovered to have variants of unknown clinical significance (UCVs). Most UCVs cause a single amino acid residue (missense) change in the BRCA1 protein. They can be biochemically assayed, but such evaluations...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics